<code id='D672B553CF'></code><style id='D672B553CF'></style>
    • <acronym id='D672B553CF'></acronym>
      <center id='D672B553CF'><center id='D672B553CF'><tfoot id='D672B553CF'></tfoot></center><abbr id='D672B553CF'><dir id='D672B553CF'><tfoot id='D672B553CF'></tfoot><noframes id='D672B553CF'>

    • <optgroup id='D672B553CF'><strike id='D672B553CF'><sup id='D672B553CF'></sup></strike><code id='D672B553CF'></code></optgroup>
        1. <b id='D672B553CF'><label id='D672B553CF'><select id='D672B553CF'><dt id='D672B553CF'><span id='D672B553CF'></span></dt></select></label></b><u id='D672B553CF'></u>
          <i id='D672B553CF'><strike id='D672B553CF'><tt id='D672B553CF'><pre id='D672B553CF'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:68347
          Adobe

          Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care clinics for seniors and funnel Medicare members into those clinics.

          It’s a formula that’s been mastered by UnitedHealth Group, which is both the country’s largest Medicare Advantage insurer and one of the biggest physician employers. Even so, investors signaled they think Humana and CVS can catch up, sending both companies’ stock prices higher after their respective second quarter earnings calls Wednesday morning.

          advertisement

          Both Humana and CVS, which owns the insurer Aetna, have made major leaps into primary care for older adults in recent years. Humana is partnering with a private equity firm to add more CenterWell Senior Primary Care sites, while CVS bought the Medicare provider Oak Street Health in May.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day
          Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

          InthisimagefromvideomadeavailableonSaturday,Aug.5,2023,aseabornedroneapproachesaRussiantankerontheBl

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo